New treatment approved for postpartum depression


THREATENING ILLNESS… AND NOW THERE MAY FINALLY BE A TREATMENT… THE INTRAVENOUS DRUG “BREXALONE” WILL BE SOLD AS ZULTRESSO… SPECIFICALLY INDICATED FOR WOMEN SUFFERING FROM POSTPARTUM DEPRESSION. THE F-D-A APPROVED DRUG SHOWS RESULTS WITHIN HOURS! THE TREATMENT REQUIRES A CONTINUOUS I-V DRIP FOR 60 HOURS… SHOWING MINOR SIDE EFFECTS SUCH AS HEADACHES, AND

Leave a Reply

Your email address will not be published. Required fields are marked *